LYKA LABS LTD. - 500259 - Letter of Offer
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Shareholders of Lyka Labs Ltd ("Target Company").19-01-2022
19-01-2022
LYKA LABS LTD. - 500259 - Shareholding for the Period Ended December 31, 2021
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here14-01-2022
LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31st December, 2021 received form M/s Link Intime India Pvt Ltd, Registrar and Share Transfer Agent of the Company.14-01-2022
LYKA LABS LTD. - 500259 - Board Meeting Intimation for Board Meeting For Consideration Of Financial Results
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2022 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors of Lyka Labs Limited is scheduled to be held on Thursday, 20th January, 2022 at Corporate Office situated at Spencer Building, Ground Floor, 30 Forjett Street, Tardeo, Grant Road West, Mumbai - 400036, to consider and adopt Standalone and Consolidated Un-Audited Financial Results for the Third Quarter ended on 31st December, 2021. As informed earlier, the trading window is closed from 1st January, 2022 till 48 hours after declaration of Un- Audited Financial Results for the Third Quarter ended 31st December, 2021.13-01-2022
LYKA LABS LTD. - 500259 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush G HindiaDesignation :- Company Secretary and Compliance Officer12-01-2022
LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 04, 2022 for Kunal Narendra Gandhi04-01-2022
LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 04, 2022 for Kunal Narendra Gandhi04-01-2022
LYKA LABS LTD. - 500259 - Closure of Trading Window
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015, the trading window for dealing in the equity shares of the Company by designated persons and their immediate relatives shall remain closed with effect from 01st January, 2022 to 48 hours after the declaration of un-audited Financial Results for the Third Quarter ended 31st December, 2021.31-12-2021
LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 30, 2021 for Kunal Narendra Gandhi30-12-2021
LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 28, 2021 for Kunal Narendra Gandhi28-12-2021